Asunto(s)
Anticuerpos Monoclonales Humanizados/efectos adversos , Benzodiazepinonas/efectos adversos , Carcinoma Hepatocelular/tratamiento farmacológico , Dermatitis Fototóxica/etiología , Erupciones por Medicamentos/etiología , Inmunoconjugados/efectos adversos , Neoplasias Hepáticas/tratamiento farmacológico , Administración Tópica , Adulto , Anticuerpos Monoclonales Humanizados/uso terapéutico , Benzodiazepinonas/uso terapéutico , Biopsia con Aguja , Carcinoma Hepatocelular/patología , Clobetasol/uso terapéutico , Dermatitis Fototóxica/tratamiento farmacológico , Dermatitis Fototóxica/patología , Erupciones por Medicamentos/patología , Femenino , Estudios de Seguimiento , Humanos , Hidrocortisona/uso terapéutico , Inmunoconjugados/uso terapéutico , Inmunohistoquímica , Neoplasias Hepáticas/patología , Resultado del TratamientoAsunto(s)
Eritromelalgia/diagnóstico , Eritromelalgia/etiología , Policitemia Vera/complicaciones , Policitemia Vera/diagnóstico , Trombocitemia Esencial/complicaciones , Trombocitemia Esencial/diagnóstico , Biomarcadores , Terapia Combinada , Eritromelalgia/terapia , Femenino , Humanos , Masculino , Mutación , Policitemia Vera/terapia , Evaluación de Síntomas , Trombocitemia Esencial/terapiaRESUMEN
Due to extensive advertising of black salve's effectiveness in "curing" skin cancers and healing other skin conditions, many patients are turning to self-treating with black salve. Although black salve has not been proven to have anticancer properties, application of black salve has been shown to cause damage to healthy tissue and the need for further treatment. We describe a 35-year-old woman whose one-time application of black salve to a healing biopsy site resulted in skin erosion and formation of a dermatitic plaque with subsequent scarring. Dermatologists and other health professionals need to be aware of this increasingly popular product to be able to better inform and treat their patients.
Asunto(s)
Terapias Complementarias/efectos adversos , Sanguinaria/efectos adversos , Enfermedades de la Piel/tratamiento farmacológico , Femenino , Humanos , Persona de Mediana Edad , Piel/efectos de los fármacos , Piel/patologíaRESUMEN
BACKGROUND: Wide local excision with 5-mm margins is the standard of care for lentigo maligna (LM). Mohs micrographic surgery (MMS) is used increasingly to treat this tumor. OBJECTIVE: To study the authors' experience with these 2 approaches. MATERIALS AND METHODS: Primary LM cases treated at the authors' institution from January 1, 1995, through December 31, 2005, were studied retrospectively. Main outcome measures were recurrence and outcomes after treatment for recurrence. RESULTS: In total, 423 LM lesions were treated in 407 patients: 269 (64%) with wide excision and 154 (36%) with MMS. In the MMS group (primarily larger head and neck lesions with indistinct clinical margins), recurrence rates were 3 of 154 (1.9%). In the wide excision group (primarily smaller, nonhead and neck, or more distinct lesions), recurrence rates were 16 of 269 (5.9%). Each of the 16 recurrences was biopsy proven and treated surgically: 6 by standard excision and 10 by MMS. CONCLUSION: This follow-up study of LM surgical treatments shows excellent outcomes for wide excision and MMS. Because this is a nonrandomized retrospective study, no direct comparisons between the 2 treatments can be made. When recurrences occurred, repeat surgery, either standard excision or MMS, was usually sufficient to provide definitive cure.
Asunto(s)
Procedimientos Quirúrgicos Dermatologicos , Peca Melanótica de Hutchinson/cirugía , Cirugía de Mohs , Femenino , Estudios de Seguimiento , Humanos , Masculino , Recurrencia Local de Neoplasia/cirugía , Reoperación , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
BACKGROUND: Sebaceous carcinoma (SC) is a rare cutaneous neoplasm. OBJECTIVE: To characterize SC and treatment approaches and outcomes. METHODS AND MATERIALS: We retrospectively reviewed records of patients with SC from 1992 through 2012. Recurrence-free survival was estimated and compared between groups. RESULTS: We identified 52 patients with SC (39, 75.0% male). Mean age ± standard deviation at diagnosis was 72.7 ± 10.8. Forty-nine patients (94.2%) were white. Twenty-one (of 29 with known status) had a diagnosis of Muir-Torre syndrome. Six had multiple primary SCs (total of 73 SCs in 52 patients). The most common locations for SC were the back (20.5%), cheek (13.7%), nose (11.0%), and eye (9.6%). Treatment was recorded for 70 SCs; 35 (50.0%) were treated using Mohs micrographic surgery (MMS) and 26 (37.1%) using wide local excision (WLE). Of the 45 patients (66 SCs) with clinical follow-up, three (6.7% of patients; 4.8% of SCs) had documented recurrence. CONCLUSION: MMS and WLE are effective treatments for SC. Further research is warranted to determine whether one treatment is more efficacious than the other.
Asunto(s)
Adenocarcinoma Sebáceo/cirugía , Cirugía de Mohs , Neoplasias Cutáneas/cirugía , Adenocarcinoma Sebáceo/patología , Anciano , Supervivencia sin Enfermedad , Femenino , Humanos , Masculino , Estudios Retrospectivos , Neoplasias Cutáneas/patología , Resultado del TratamientoRESUMEN
BACKGROUND: The incidence of lentigo maligna (LM) may be increasing, but no population-based epidemiologic studies have been performed to our knowledge. OBJECTIVE: We sought to determine the incidence of LM in Olmsted County, Minnesota, along with overall and recurrence-free survival. METHODS: Using the Rochester Epidemiology Project, we identified all adult residents of Olmsted County, Minnesota, with a first lifetime diagnosis of LM between 1970 and 2007. Medical records were reviewed to determine demographic, clinical, and surgical data, and incidence and survival were calculated. RESULTS: Among 145 patients identified, median (range) age at diagnosis of LM was 70 (33-97) years. Treatment changed over time, with Mohs micrographic surgery becoming available after 1986. No patients died of LM; 5 had local recurrence. Estimated local recurrence-free survival at 5, 10, 15, and 20 years after diagnosis was 98%, 96%, 92%, and 92%, respectively. Overall age- and sex-adjusted incidence of LM among adults was 6.3 per 100,000 person-years, increasing from 2.2 between 1970 and 1989 to 13.7 between 2004 and 2007. LIMITATIONS: Retrospective study design and homogeneous population are limitations. CONCLUSION: The incidence of LM increased significantly among residents of Olmsted County, Minnesota, over an extended time frame, with incidence being significantly higher among men than women and increasing with age.